Please verify

Blaze Media
Watch LIVE

Washington Post cites old Romney critics to revive Olympics 'questions


The lead story for the Washington Post today is about the "questions" surrounding Mitt Romney's contributions to the winter Olympics of 2002. But the "questions" aren't new and the article actually cites three people who have been critical of Romney in similar past articles going back to the last presidential election.

First is the bitter Ken Bullock, executive director of the Utah League of Cities and Towns. "What’s offensive to me is he made it about him and not our community and not our state,” Bullock told the Post. “People should remember the Games, not the individual.”

Bullock publicly comments on Romney's role in the Olympics like an angry ex-girlfriend. "It was the Mitt show," Bullock told the New York Times in 2007. And in 2008 he told the L.A Times, "[Romney] had his role, but he didn't save the Games by any stretch of the imagination."

Next is Robert Garff, the friend of convenience. Garff is chairman of the Salt Lake City Olympics committee and the guy who picked Romney to help turn around the scandal-ridden Games.

Garff told the Post "it was fairly obvious" that Romney's decision to help fix the Olympic problem was a politically-motivated one. Garff said the same thing in 2007: "It was obvious that he had an agenda larger than just the Olympics," he said to the New York Times.

Finally, there's Stephen Pace who was a member of the nonprofit Utahns for Responsible Public Spending. In 2008, Pace told the L.A Times that Romney "takes credit for cleaning everything up," but that Romney's contribution to the Olympics was "hard to tell." In the Post's story, he says as much again: "[Romney] didn’t disabuse anyone of the notion he saved everyone’s bacon."

Did Romney help "save" the Olympics, as he has said in a political ad in 2011? PolitiFact says the claim is "mostly true." But, per the Post, don't forget there are stillthe same people saying stuff some questions.

Most recent

Elon Musk's Neuralink receives FDA green light for 'first-in-human clinical study'

All Articles